PAPER
Synthesis of N-Protected Diphenyl 1-Aminoalkylphosphonates
637
MS (ESI): m/z = 440 (M+ + 1), 462 (M+ + Na).
5.08 (br s, 2 H, CH2OC), 7.07–7.18 (m, 6 Harom), 7.20–7.28 (m, 4
arom), 7.29–7.38 (m, 5 Harom).
31P NMR (CDCl3, 109 MHz): d = 19.67.
H
Anal Calcd for C24H26NO5P (439): C, 65.60; H, 5.92; N, 3.19.
Found: C, 65.46; H, 6.06; N, 3.32.
MS (ESI): m/z = 466 (M+ + 1), 488 (M+ + Na).
Diphenyl (2E)-1-[(tert-Butoxycarbonyl)amino]-3-phenylprop-
2-enylphosphonate (8)
Anal. Calcd for C26H28NO5P (465.48): C, 67.09; H, 6.06; N, 3.01.
Found: C, 67.03; H, 6.15; N, 3.09.
1H NMR (CDCl3, 400 MHz): d = 1.46 (s, 9 H, t-C4H9), 5.23 (br s, 2
H, NCHP + NH), 6.32 (ddd, 1 H, J = 6, 12, 16 Hz, =CH), 6.74 (dd,
1 H, J = 4.4, 16 Hz, =CH), 7.13–7.38 (m, 15 Harom).
Diphenyl 1-{[(Benzyloxy)carbonyl]amino}-1-methylbutylphos-
phonate (14)
31P NMR (CDCl3, 109 MHz): d = 14.89.
MS (ESI): m/z = 466 (M+ + 1), 488 (M+ + Na).
1H NMR (CDCl3, 400 MHz): d = 0.90–1.00 (m, 3 H, CH3), 1.47–
1.58 (br m, 2 H, CH2), 1.81 (d, 3 H, J = 17.6 Hz, CH3), 1.93–2.05
(m, 1 H, CH2), 2.19–2.31 (m, 1 H, CH2), 5.06 (br s, 3 H, CH2OC +
NH), 7.09–7.33 (m, 15 Harom).
Anal Calcd for C26H28NO5P (465): C, 67.10; H, 6.02; N, 3.01.
Found: C, 67.43; H, 6.12; N, 3.26.
31P NMR (CDCl3, 109 MHz): d = 20.63.
Diphenyl [(tert-Butoxycarbonyl)amino](cyclohexyl)methyl-
phosphonate (9)
MS (ESI): m/z = 454 (M+ + 1), 476 (M+ + Na).
1H NMR (CDCl3, 400 MHz): d = 1.08–1.37 (m, 6 H, 3 CH2), 1.44
(s, 9 H, t-C4H9), 1.62–1.89 (m, 3 H, CH2 + CH), 1.97–2.08 (m, 2 H,
CH2), 4.36 (2 dd, 1 H, J = 10.8 Hz, NCHP), 4.97 (dd, 1 H, J = 8.4,
10.8 Hz, NH), 7.11–7.23 (m, 6 Harom), 7.26–7.37 (m, 4 Harom).
Anal. Calcd for C25H28NO5P (453.47): C, 66.22; H, 6.22; N, 3.09.
Found: C, 66.04; H, 6.33; N, 3.16.
Diphenyl 1-Benzyl-1-{[(benzyloxy)carbonyl]amino}ethylphos-
phonate (15)
31P NMR (CDCl3, 109 MHz): d = 18.45.
MS (ESI): m/z = 446 (M+ + 1), 468 (M+ + Na).
1H NMR (CDCl3, 400 MHz): d = 1.72 (d, 3 H, J = 17.2 Hz, CH3),
3.15–3.23 (m, 1 H, CH2), 3.75–3.82 (m, 1 H, CH2), 4.98 (br s, 1 H,
NH), 5.09 (br s, 2 H, CH2OC), 7.05–7.35 (m, 20 Harom).
Anal Calcd for C24H32NO5P (445): C, 64.72; H, 7.19; N, 3.15.
Found: C, 64.96; H, 7.23; N, 3.33.
31P NMR (CDCl3, 109 MHz): d = 19.86.
MS (ESI): m/z = 502 (M+ + 1), 524 (M+ + Na).
Diphenyl 1-[(tert-Butoxycarbonyl)amino]-3-methylbutylphos-
phonate (10)
Anal. Calcd for C29H28NO5P (501.51): C, 69.45; H, 5.63; N, 2.79.
Found: C, 69.20; H, 5.64; N, 2.58.
1H NMR (CDCl3, 400 MHz): d = 0.94–1.01 (m, 6 H, 2 CH3), 1.43
(s, 9 H, t-C4H9), 1.66–1.89 (m, 3 H, CH + CH2), 4.45–4.58 (m, 1 H,
NCHP), 4.80 (d, 1 H, J = 10.4 Hz, NH), 7.12–7.22 (m, 6 Harom),
7.26–7.35 (m, 4 Harom).
Acknowledgment
31P NMR (109 MHz, CDCl3): d = 19.44.
MS (ESI): m/z = 420 (M+ + 1), 442 (M+ + Na).
P. Van der Veken and J. Joossens are fellows of the Institute of Pro-
motion and Innovation in Science and Technology of Flanders
(IWT). I. El Sayed is a visiting post-doctoral fellow of the Fund of
Scientific Research, Flanders. We thank Prof. M. Soroka (Technical
University of Wrocław, Poland) for helpful discussions.
Anal Calcd for C22H30NO5P (419): C, 63.00; H, 7.16; N, 3.34.
Found: C, 63.06; H, 7.23; N, 3.48.
Diphenyl 1,3-Benzodioxol-5-yl-[(tert-butoxycarbonyl)ami-
no]methylphosphonate (11)
References
1H NMR (CDCl3, 400 MHz): d = 1.41 (s, 9 H, t-C4H9), 5.42 (dd, 1
H, J= 8.8, 9.2 Hz, NCHP), 5.69–5.79 (br m, 1 H, NH), 5.93 (s, 2 H,
OCH2O), 6.77 (d, 1 Harom, J = 8 Hz), 6.92–7.00 (m, 4 Harom), 7.08–
7.33 (m, 8 Harom).
(1) (a) Oleksyszyn, J.; Subotkowska, L.; Mastalerz, P. Synthesis
1979, 985. (b) Oleksyszyn, J.; Tyka, R. Tetrahedron Lett.
1977, 18, 2823.
(2) (a) Oleksyszyn, J.; Tyka, R.; Mastalerz, P. Synthesis 1979,
985. (b) Birum, G. H. J. Org. Chem. 1974, 39, 209.
(3) For a review, see: Kukhar, V. P.; Hudson, H. R.
Aminophosphonic- and Aminophosphinic Acids. Chemistry
and Biological Activity; Wiley: Chichester, 2000.
(4) Examples of diphenyl 1-aminoalkylphosphonates as enzyme
inhibitors: (a) Boduszek, B.; Oleksyszyn, J.; Kam, C. M.;
Selzer, J.; Smith, R. E.; Powers, J. C. J. Med. Chem. 1994,
37, 3969. (b) Oleksyszyn, J.; Boduszek, B.; Kam, C.-M.;
Powers, J. C. J. Med. Chem. 1994, 37, 226. (c) Bertrand, J.
A.; Oleksyszyn, J.; Kam, C.-M.; Boduszek, B.; Presnell, S.;
Plaskon, R. R.; Suddath, F. L.; Powers, J. C.; Williams, L. D.
Biochemistry 1996, 35, 3147. (d) Belyaev, A.; Zhang, X.;
Augustyns, K.; Lambeir, A.-M.; de Meester, I.;
31P NMR (CDCl3, 109 MHz): d = 14.90.
MS (ESI): m/z = 484 (M+ + 1), 506 (M+ + Na).
Anal. Calcd for C25H26NO7P (483): C, 62.11; H, 5.38; N, 2.89.
Found: C, 62.15; H, 5.39; N, 3.12.
Diphenyl 1-{[(Benzyloxy)carbonyl]amino}-1-phenylethylphos-
phonate (12)
1H NMR (CDCl3, 400 MHz): d = 2.34 (d, 3 H, J = 17.6 Hz, CH3),
5.07 (br s, 2 H, CH2OC), 6.13 (d, 1 H, J = 11.2 Hz, NH), 6.80–7.62
(m, 20 Harom).
31P NMR (CDCl3, 109 MHz): d = 17.22.
MS (ESI): m/z = 488 (M+ + 1), 510 (M+ + Na).
Vedernikova, I.; Scharpé, S.; Haemers, A. J. Med. Chem.
1999, 42, 1041. (e) Nishiyama, Y.; Taguchi, H.; Luo, J. Q.;
Zhou, Y. X.; Burr, G.; Karle, S.; Paul, S. Arch. Biochem.
Biophys. 2002, 402, 281. (f) Mucha, A.; Kafarski, P.
Tetrahedron 2002, 58, 5855. (g) Grembecka, J.; Mucha, A.;
Cierpicki, T.; Kafarski, P. J. Med. Chem. 2003, 46, 2641.
(h) Joossens, J.; Van der Veken, P.; Lambeir, A.-M.;
Augustyns, K.; Haemers, A. J. Med. Chem. 2004, 47, 2411.
Anal Calcd for C28H26NO5P (487.48): C, 68.99; H, 5.38; N, 2.87.
Found: C, 69.28; H, 5.38; N, 3.00.
Diphenyl 1-{[(Benzyloxy)carbonyl]amino}cyclohexylphospho-
nate (13)
1H NMR (CDCl3, 400 MHz): d = 1.50–1.80 (m, 6 H, 3 CH2), 1.88–
1.99 (m, 2 H, CH2), 2.54–2.66 (br s, 2 H, CH2), 4.90 (br s, 1 H, NH),
Synthesis 2005, No. 4, 634–638 © Thieme Stuttgart · New York